Details for New Drug Application (NDA): 016689

NDA 016689 describes DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.

Summary for 016689

Tradename:	DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
Applicant:	Baxter Hlthcare
Ingredient:	dextrose; sodium chloride
Patents:	0

Pharmacology for NDA: 016689

Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Suppliers and Packaging for NDA: 016689

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	016689	NDA	Baxter Healthcare Corporation	0338-0077	0338-0077-02	36 BAG in 1 CARTON (0338-0077-02) / 250 mL in 1 BAG
DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	016689	NDA	Baxter Healthcare Corporation	0338-0077	0338-0077-03	24 BAG in 1 CARTON (0338-0077-03) / 500 mL in 1 BAG

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	5GM/100ML;200MG/100ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	No

Complete Access Available with Subscription